Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-20-014029
Filing Date
2020-09-30
Accepted
2020-09-30 16:00:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a093020crdf424b5.htm 424B5 729037
2 cardiff_logoxrgbxtm2.jpg GRAPHIC 176318
3 g210381dei0011.jpg GRAPHIC 3646
  Complete submission text file 0001628280-20-014029.txt   963736
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-232321 | Film No.: 201212260
SIC: 2836 Biological Products, (No Diagnostic Substances)